Michael R. Jones

发表

Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.

S. Schwartz, F. Zieve, M. Kalin, 2007, Clinical therapeutics.

Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes.

R. Rosenson, Stacey L. Abby, Michael R. Jones, 2009, Atherosclerosis.

Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.

J. Rosenstock, R. Goldberg, W. Garvey, 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Colesevelam HCl to Treat Hypercholesterolemia and Improve Glycemia in Prediabetes: A Randomized, Prospective Study

J. Rosenstock, W. Garvey, V. Fonseca, 2010 .

Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based Therapy

J. Rosenstock, V. Fonseca, K. Truitt, 2008, Diabetes Care.

Colesevelam hydrochloride does not cause maternal or fetal toxicity in rats and rabbits.

B. Baker, J. Marquis, Michael R. Jones, 2006, Reproductive toxicology.

Colesevelam improved lipoprotein particle subclasses in patients with prediabetes and primary hyperlipidaemia

R. Rosenson, R. Goldberg, S. Misir, 2013, Diabetes & vascular disease research.

Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.

H. Bays, M. Davidson, Stacey L. Abby, 2006, The American journal of cardiology.

Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.

R. Goldberg, H. Bays, K. Truitt, 2008, Archives of internal medicine.

Role of Colesevelam in Combination Lipid-Lowering Therapy

Michael R. Jones, O. Nwose, Michael R. Jones, 2013, American Journal of Cardiovascular Drugs.

Safety and Efficacy of Colesevelam HCl in the Treatment of Elderly Patients

J. Gavin, K. Truitt, Michael R. Jones, 2014, Drugs & Aging.

Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes

S. Mudaliar, A. Unnikrishnan, Stacey L. Abby, 2009, Current medical research and opinion.

Single‐Dose Pharmacokinetics of Sodium Ferric Gluconate Complex in Iron‐Deficient Subjects

N. Dahl, H. Kimko, M. Ducharme, 2004, Pharmacotherapy.

Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.

R. Goldberg, V. Fonseca, K. Truitt, 2008, Archives of internal medicine.

Effects of colesevelam, rosiglitazone, or sitagliptin on glycemic control and lipid profile in patients with type 2 diabetes mellitus inadequately controlled by metformin monotherapy.

Y. Handelsman, Stacey L. Abby, Michael R. Jones, 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Atypical Mechanism of Glucose Modulation by Colesevelam in Patients with Type 2 Diabetes

Michael R. Jones, O. Nwose, Michael R. Jones, 2013, Clinical medicine insights. Endocrinology and diabetes.

Clinical Effects of Colesevelam in Hispanic Subjects with Primary Hyperlipidemia and Prediabetes

J. Rosenstock, Y. Handelsman, Michael R. Jones, 2012, Postgraduate medicine.

Initial Combination Therapy with Metformin plus Colesevelam in Drug-Naïve Hispanic Patients with Early Type 2 Diabetes

J. Rosenstock, Y. Handelsman, S. Nagendran, 2012, Postgraduate medicine.

Lipid-lowering effects of colesevelam HCl in combination with ezetimibe*

H. Bays, Stacey L. Abby, Y. Lai, 2006, Current medical research and opinion.

Safety and efficacy of colesevelam hydrochloride in combination with fenofibrate for the treatment of mixed hyperlipidemia

J. Mckenney, Stacey L. Abby, Michael R. Jones, 2005, Current medical research and opinion.

The effect of colesevelam hydrochloride on insulin sensitivity and secretion in patients with type 2 diabetes: a pilot study.

S. Schwartz, Jianbo Xu, Stacey L. Abby, 2010, Metabolic syndrome and related disorders.

Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.

J. Rosenstock, R. Goldberg, W. Garvey, 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Colesevelam HCl Improves Fasting Plasma Glucose and Lipid Levels in Patients with Prediabetes

Y. Handelsman, Stacey L. Abby, Xiao-ping Jin, 2009, Postgraduate medicine.

A 50-Week Extension Study on the Safety and Efficacy of Colesevelam in Adults with Primary Hypercholesterolemia

M. Davidson, Michael R. Jones, S. Misir, 2010, American journal of cardiovascular drugs : drugs, devices, and other interventions.

Colesevelam HCl Improves Glycemic Control and Reduces LDL-Cholesterol in Patients with Type 2 Diabetes Inadequately Controlled on Sulfonylurea-Based Therapy

J. Rosenstock, V. Fonseca, K. Truitt, 2008 .

Dietary Administration of Colesevelam Hydrochloride Does Not Affect Fertility or Reproductive Performance in Rats

J. Marquis, Michael R. Jones, R. Dagher, 2004, International journal of toxicology.

Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.

R. Goldberg, V. Fonseca, K. Truitt, 2008, Archives of internal medicine.